Clinical trials
Terminated Sarcoma, Kaposi trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| AIDS Malignancy Consortium | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Alpha Tau Medical LTD. | 1 |
| Case Comprehensive Cancer Center | 1 |
| Fred Hutchinson Cancer Center | 1 |
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Kaposi | 13 |
| Sarcoma | 5 |
| HIV Infections | 4 |
| Acquired Immunodeficiency Syndrome | 2 |
| Basal Cell Carcinoma | 2 |
| Castleman Disease | 2 |
| Lymphoma | 2 |
| Neoplasm Metastasis | 2 |
| Skin Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.